The global pseudomonas aeruginosa pneumonia drug market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). The key companies operating in the industry are highly inclined towards the adoption of different growth strategies including capacity expansion, partnerships, mergers, and acquisitions, geographical expansions, and product innovations to remain competitive in the market. For instance, in June 2019, Merck & Co has received the approval of the US Food and Drug Administration (FDA) for the use of Zerbaxa. The Zerbaxa is used to treat adult patients ( 18 years and older) with hospital-acquired bacterial infection pneumonia and ventilator-associated pneumonia which is caused by the susceptible gram-negative microorganisms. The company further stated that efficacy was assessed based on all-cause mortality at day 28 and significant signs of improvement occurred after 7 to 14 days at the end of the treatment.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/pseudomonas-aeruginosa-pneumonia-drug-market
Moreover, in 2019, Teva Pharmaceuticals has launched a Tobramycin inhalation solution. This solution is packaged in plastic containers called ampules. The medicine is used to treat lung infections in patients with cystic fibrosis. Furthermore, in June 2020, Merck & Co received US Food and Drug Administration (FDA) approval for the use of Recarbrio. Recarbrio is used to treat adult patients ( 18years and older) with hospital-acquired bacterial infection pneumonia and ventilator-associated pneumonia. Moreover, recarbrio was previously approved by FDA to treat patients with urinary tract infections who possess no alternative treatments. According to FDA, the safety and efficacy were evaluated in clinical trials of 535 hospitalized adults with VABP. Thus, the application was designated as Qualified Infectious Disease Program (QIDP) by the FDA.
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
Segment Covered-
- By Type
- By Application
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape- Aridis Pharmaceuticals LLC, Johnson & Johnson Services Inc., Medlmmune LLC (Astrazeneca), Pfizer Inc., and more among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Pseudomonas Aeruginosa Pneumonia Drug Market Report Segment
By Type
- Aerucin
- EV-035
- MEDI-3902
- Others
By Application
- Hospitals
- Clinics
- Others
A full report of Pseudomonas Aeruginosa Pneumonia Drug Market is available at: https://www.omrglobal.com/industry-reports/pseudomonas-aeruginosa-pneumonia-drug-market
Pseudomonas Aeruginosa Pneumonia Drug Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- AbbVie Inc.(Allergan)
- Bayer AG
- Bristol-Myers Squibb Co.
- CARB-X
- Reddy’s Laboratories Ltd.
- Emergent BioSolutions
- Merck &Co.
- Novartis International AG
- Polyphor Ltd.
- Pfizer Inc.
- Teva Pharmaceuticals Industries Ltd.
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
